20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes
Year: 2008
Type: conference-paper
Language: English
Topic: Vitamin D Research Studies
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2611124348
